Role of monoclonal antibody drugs in the treatment of COVID-19

doi:10.12998/wjcc.v8.i19.4280

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10229)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

802

WORD

212

HTML

5454

Figures (1-1)

659

Tables (1-2)

353

Sum=7480

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

421

Download

779

Sum=1200

Publishing Process of This Article

Item

Count

Browse

614

Download

935

Sum=1549

Oct 6, 2020 (publication date) through Jan 24, 2025

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Opinion Review

World J Clin Cases. Oct 6, 2020; 8(19): 4280-4285
Published online Oct 6, 2020. doi: 10.12998/wjcc.v8.i19.4280

Open in New Tab Full Size Figure Download Figure

Figure 1 The Janus kinase/signal transducer and activator of tran-ions pathway. IFN: Interferon; IL: Interleukin; JAK: Janus kinase; STAT: Signal transducer and activator of tran-ions.

Citation: Ucciferri C, Vecchiet J, Falasca K. Role of monoclonal antibody drugs in the treatment of COVID-19. World J Clin Cases 2020; 8(19): 4280-4285
URL: https://www.wjgnet.com/2307-8960/full/v8/i19/4280.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i19.4280